Clinical trials

Clinical trials offer patients the opportunity to have treatment options and imaging options that might not otherwise be accessible.  There are literally thousands of clinical trials for neuroendocrine cancer patients around the world. In addition to approved peptide receptor radionuclide therapy with Lutathera and the Gallium-68 PET/CT scan with NETSPOT, in some parts of the world, there are also clinical trials with different radionuclides for PRRT,  trials for the Gallium scan, personalized PRRT , etc.

The U.S. National Institutes of Health, through its National Library of Medicine, has developed ClinicalTrials.gov to provide patients, family members and members of the public current information about clinical research studies.
Using the links below you can see which PRRT and Gallium scan trials are open and recruiting, which have completed, which are not yet recruiting, etc.

The above links are the results of searches using the search terms Neuroendocrine Tumors and Peptide Receptor Radionuclide Therapy and Neuroendocrine Tumors and Gallium Scan. It is possible if you enter other terms, such as carcinoid or neuroendocrine tumors and a specific location in the body, you might get other results. You can also enter a specific country or do more advanced searches.

Begin here for additional searches: https://clinicaltrials.gov/ct2/home

Other links

Clinical Trials, What Patients Need to Know

From the U.S. Food and Drug Administration ( also available in Spanish )

Why should I participate in a clinical trial?

From the U.S. National Institute of Health